Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Cherry Hill, New Jersey Clinical Trials

A listing of Cherry Hill, New Jersey clinical trials actively recruiting patient volunteers.

RESULTS

Found (2073) clinical trials

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Phase

0.45 miles

Learn More »

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

This study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive treatment to ongoing anti-depressive therapy (ADT) in the prevention of relapse in participants with Major Depressive Disorder (MDD).

Phase

0.45 miles

Learn More »

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Phase

0.45 miles

Learn More »

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Patients With Bipolar I Disorder

This study is designed to prospectively confirm the efficacy of a fixed-dose regimen of cariprazine 1.5 mg/day or 3 mg/day compared to placebo for treatment of the depressive episode in patients with bipolar I disorder. The safety and tolerability of the fixed-dose regimens will be evaluated.

Phase

0.45 miles

Learn More »

A clinical research study evaluating an investigational drug for its safety and effectiveness in the treatment of Major Depressive Disorder Eligibility Criteria: Be 18 to 65 years old Diagnosed with Major Depressive Disorder Not getting adequate results with current antidepressant therapy Other Details: Eligible participants will receive investigational drug as ...

Phase N/A

0.45 miles

Learn More »

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

To investigate the efficacy, safety and tolerability of BI 409306 once daily compared to placebo given for 52 weeks to subjects with attenuated psychosis syndrome.

Phase

0.45 miles

Learn More »

A clinical research study evaluating an investigational drug for Its safety and effectiveness in the treatment of Bipolar Depression

Phase N/A

0.45 miles

Learn More »

If you are living with OCD, you may be interested in participating in a clinical research study of an investigational medication for adults with OCD.   OCD patients not satisfied taking an SSRI: You may be eligible to participate in a study with an investigational medication that would be added ...

Phase N/A

0.45 miles

Learn More »

When psychosis develops, people often suffer symptoms, sometimes for many months. In some people, these symptoms may be an early sign that more serious mental health problems may develop. If you (or a loved one) are living with any of these symptoms, you may be wondering about the development of ...

Phase N/A

0.45 miles

Learn More »

Every day can be unpredictable when your loved one has agitation due to Alzheimer’s disease.  The TRIAD™ Research Study is currently evaluating an investigational medication to see if it may reduce symptoms of agitation due to Alzheimer’s disease.  

Phase N/A

0.45 miles

Learn More »